Full Citation
Title: A cost-effectiveness analysis of pretreatment DPYD and UGT1A1 screening in patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI+bevacizumab (FOLFIRI+Bev).
Citation Type: Journal Article
Publication Year: 2020
ISBN:
ISSN:
DOI: 10.1200/JCO.2020.38.4_SUPPL.168
NSFID:
PMCID:
PMID:
Abstract: 168Background: Variants in DPYD and UGT1A1 impact toxicities experienced by patients being treated with FOLFIRI+bev. Testing allows providers to preemptively adjust dosing, reducing the toxicity th...
User Submitted?: No
Authors: Rivers, Zachary; Stenehjem, David D.; Jacobson, Pamala; Lou, Emil; Nelson, Andrew; Kuntz, Karen M
Periodical (Full): https://doi.org/10.1200/JCO.2020.38.4_suppl.168
Issue: 4_suppl
Volume: 38
Pages: 168-168
Countries: